As generative and agentic AI reshapes productivity in life sciences, commercial and medical teams are experiencing significant change. For emerging biopharma companies, the focus is shifting beyond operational efficiency. In response, biopharma leaders are rearchitecting team structures, integrating digital colleagues and expanding partnerships to compete in the AI-powered era.
Join Mayank Misra, VP commercial strategy, analytics and operations at Soleno Therapeutics and Bharat Tandon, principal at ZS, for a conversation about how life sciences organizations are leveraging AI now with an eye to the future. They’ll share how to create scalable, intelligent value across commercial functions, from first launch to commercialization and beyond.
Whether you’re adapting your current operating model or preparing for what's next, this webinar will provide a framework for a future-ready, value-driven commercial organization.
Mayank Misra is VP, Commercial Strategy, Analytics & Operations at Soleno Therapeutics. With over 20 years in biopharma, including leadership roles at Pfizer, Takeda Oncology, and Melinta, he drives commercialization strategy, analytics, product launches and operational excellence. He holds an M.S. in Data Sciences & ML from Columbia and an MBA.
Bharat Tandon is a Principal at ZS based in the San Francisco Bay Area. He leads strategic analytics and consulting initiatives for pharmaceutical and biotech clients, leveraging deep domain expertise to design scalable solutions that drive launch effectiveness and long-term growth.